How many clinical trials are running for divarasib?

ClinicalTrials.gov currently lists 7 phase 2–4 divarasib trials: 3 phase 2, 4 phase 3, and 0 phase 4. 3 are actively recruiting.

Where does this data come from?

All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.

Can I compare divarasib against other drugs?

Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.

KRAS inhibitors · Live ClinicalTrials.gov data

Divarasib clinical trial pipeline

ClinicalTrials.gov lists 7 phase 2–4 trials for divarasib, 3 of them actively recruiting. The next phase 3 primary completion among them is expected Nov 2028. Refreshed daily — add up to four competitors to compare pipelines side by side.

Phase 2–4 trials

Phase 3 trials

Actively recruiting

Nov 2028

Next phase 3 primary completion

3,457

Participants across trials

Hoffmann-La Roche

Lead sponsor by trial count

divarasib (7)7 active2017–2034

Hide completed

divarasib

Key

Actual date

Anticipated

Forecast to primary completion

RecruitingActive, not recruitingNot yet recruiting

'17

'19

'21

'23

'25

'27

'29

'31

'33

divarasib

B-FASTP2

NAUTIKA1P2

Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform StudyP2

UmbrellaMAXP3

Krascendo 1P3

Krascendo 2P3

KRASCENDO 3P3

Upcoming readouts

6 ahead · divarasib

Select a trial to load its full ClinicalTrials.gov record.

Key divarasib trials

Top 7 of the 7 registered phase 2–4 trials, ordered by phase and status. Each links to its full ClinicalTrials.gov record.

Trial	Title	Phase	Status	Primary completion
NCT06793215	Krascendo 2 — A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed …	Phase 3	Recruiting	Nov 2028
NCT05862285	UmbrellaMAX — A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Stud…	Phase 3	Recruiting	Mar 2033
NCT06497556	Krascendo 1 — A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Pre…	Phase 3	Active, not recruiting	May 2026
NCT07541170	KRASCENDO 3 — A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy …	Phase 3	Not yet recruiting	Jan 2032
NCT04302025	NAUTIKA1 — A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell …	Phase 2	Recruiting	Nov 2026
NCT03178552	B-FAST — A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With…	Phase 2	Active, not recruiting	Oct 2026
NCT04589845	Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study	Phase 2	Active, not recruiting	Sept 2032

Compare divarasib vs sotorasib Compare divarasib vs adagrasib

FAQ

How many clinical trials are running for divarasib?: ClinicalTrials.gov currently lists 7 phase 2–4 divarasib trials: 3 phase 2, 4 phase 3, and 0 phase 4. 3 are actively recruiting.
Where does this data come from?: All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
Can I compare divarasib against other drugs?: Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.

Join the waitlist

Be the first to access ComplyRx

We'll let you know as soon as your spot opens to use ComplyRx.

By joining, you agree to our Privacy Policy.

Upcoming readouts

Key divarasib trials

Related drug pipelines

FAQ

Be the first to access ComplyRx